Schonfeld Strategic Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Buy |
+21,371
| New | +$108K | ﹤0.01% | 1739 |
|
|
2025
Q1 | – | Sell |
-54,511
| Closed | -$368K | – | 2307 |
|
|
2024
Q4 | $368K | Buy |
+54,511
| New | +$368K | ﹤0.01% | 1465 |
|
|
2023
Q1 | – | Sell |
-81,204
| Closed | -$626K | – | 2468 |
|
|
2022
Q4 | $626K | Sell |
81,204
-35,807
| -31% | -$276K | 0.01% | 1392 |
|
|
2022
Q3 | $1.24M | Sell |
117,011
-55,184
| -32% | -$587K | 0.01% | 1121 |
|
|
2022
Q2 | $1.4M | Buy |
172,195
+81,395
| +90% | +$663K | 0.01% | 805 |
|
|
2022
Q1 | $650K | Buy |
+90,800
| New | +$650K | 0.01% | 1157 |
|